← All stocks

Cocrystal Pharma, Inc.

COCP Net selling
CIK 0001412486 #5004 in the set updated 18 Sep 2026
Bought (120 mo)
$2.36M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.66M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$2.66M
2 of 2 sales
Net
−$303.88K
−$303.88K against sales at will

By person

9 insiders · 20 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FROST PHILLIP MD ET AL
Director
$2.30M (12)
+$2.30M
5,675,916
29.47%
$5.57M
+47.3%
Schinazi Raymond F
10% owner
$19.04K (3)
$1.70M (1)
−$1.68M
9,600,078
49.84%
$9.42M
+167.4%
Lee Sam
President and Co-CEO
$968.00K (1)
−$968.00K
76,355
0.3964%
$74.95K
−96.6%
PFENNIGER RICHARD C JR
Director
$41.12K (1)
+$41.12K
31,400
0.1630%
$30.82K
Rubin Steven D
Director
2,660,242
13.81%
$2.61M
+0.7%
Hassan Fred
Director
1,383,009
7.18%
$1.36M
+36.2%
Martin James Joseph
Co-CEO and CFO
44,167
0.2293%
$43.35K
+7,662%
Kornberg Roger D.
Director
28,109
0.1459%
$27.59K
Japour Anthony J
Director
14,924
0.0775%
$14.65K
Insider
Date
Role
Action
Shares
Price
Amount
Schinazi Raymond F
4 May 2021
10% owner
Sell
575,000
$2.95
$1.70M
Lee Sam
23 Dec 2016
PRESIDENT
Sell
2,200,000
$0.44
$968.00K

What was left out

Form 4 filings counted 78
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 7,601,260
Sales filed before the plan box existed 2
History held since 6 Sep 2016